Product
ENZ215
1 clinical trial
1 indication
Indication
Healthy Male ParticipantsClinical trial
A Randomized, Double-blind, Three-arm, Parallel-group, Single-dose Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Denosumab (ENZ215, EU-sourced Prolia®, and US-sourced Prolia®) in Healthy Adult Male VolunteersStatus: Recruiting, Estimated PCD: 2024-05-01